Ceyhun VARIM, Tezcan KAYA, Ahmet NALBANT, Ali TAMER

Paratiroid hormon düşüklüğü: 107 olgunun etiyolojik olarak değerlendirilmesi

Amaç: Bu çalışmamızın amacı, paratiroid hormonu düşük hastaların etiyolojik olarak değerlendirilmesidir. Yöntem ve Gereçler: Çalışmaya hastanemiz dahiliye klinik ve polikliniklerinde Temmuz 2009 ile Nisan 2012 tarihleri arasında değerlendirilen, serum paratiroid hormonu düşük (

Low parathyroid hormone levels: Evaluatoin of 107 cases as etiological

Aim:In this study, we aimed to evaluate the aetiology of patients with low parathyroid hormone levels. Material and Methods: The study population included 107 of 141 patients with available records who had been evaluated at clinic, or were outpatients of internal medicine in our hospital, and had low parathyroid hormone (

PDF

___

1. Al-Azem H, Khan AA. Hypoparathyroidism. Best Pract Res Clin Endocrinol Metab 2012 Aug;26(4):517-22.
2. Endres DB. Investigation of hypercalcemia, Review Article. Clin Biochem 2012 Aug;45(12):954-63.
3. Bilezikian JP, Khan A, Potts Jr JT et al. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology,target organ involvement, treatment, and challenges for future research. J Bone Miner Res 2011; 26:2317–2337.
4. Shoback D. Clinical practice: Hypoparathyroidism. New Engl J Med 2008;359:391–403.
5. Jacobs TP, Bilezikian JP. Clinical review: rare causes of hypercal- cemia. J Clin Endocrinol Metab 2005;90:6316–22.
6. Kallas M, Green F, Hewison M, White C, Kline G. Rare causes of calcitriolmediated hypercalcemia: a case report and literature review. J Clin Endocrinol Metab 2010;95:3111–7.
7. Lee C-T, Yang C-C, Lam K-K, Kung C-T, Tsai C-J, Chen H-C. Hypercalcemia in the emergency department. Am J Med Sci 2006;331:119–23.
8. Lafferty FW. Differential diagnosis of hypercalemia. J Bone Miner Res 1991;6 (Suppl. 2):s51–9.
9. Underbjerg L, Sikjaer T, Mosekilde L, et al. The epidemiol- ogy of hypo- and pseudohypoparathyroidism in Denmark. Bone 2012;50(Suppl. 1):S171.
10. Marx SJ. Hyperparathyroid and hypoparathyroid disorders. New England Journal of Medicine 2000; 343: 1863–1875.
11. Hypoparathyroidism Association, Inc., Web site. HPTH Associa- tion, Inc., Idaho Falls, ID, USA; available at: www.hpth.org; ac- cessed 2012.
12. Shoback D. Clinical practice: hypoparathyroidism. New England Journal of Medicine 2008; 359: 391–403.
13. Söğütlü G, Çıkım AS, Ölmez A, et al. Postoperative Hypoparathy- roidism in Total Thyroidectomy: Incidence and Predictive Factors. Turk JEM 2007; 11: 16-9.
14. Bron LP, O'Brien CJ. Total thyroidectomy for clinically benign disease of the thyroid gland. Br J Surg 2004; 91: 569-74.
15. Rosato L, Avenia N, Bernante P, et al. Complications of thyroid surgery: analysis of amulticentric study on 14,934 patients operated on in Italy over 5 years. World J Surg. 2004; 28: 271-6.
16. Page C, Strunski V. Parathyroid risk in total thyroidectomy for bi- lateral, benign, multinodular goiter: Report of 351 surgical cases. J Laryngol Otol. 2007;121:237–41.
17. Richards ML, Thompson GB, Farley DR et al. Reoperative parathyroidectomy in 228 patients during the era of minimalaccess surgery and intraoperative parathyroid hormone monitoring. American Journal of Surgery 2008; 196: 937–943.
18. Thomusch O, Machens A, Sekulla C, et al. The impact of surgical technique on postoperative hypoparathyroidism in bilateral thyroid surgery: a multivariate analysis of 5846 consecutive patients. Surgery. 2003;133:180–95.
19. Zarnegar R, Brunaud L, Clark OH. Prevention, evaluation, and management of complications following thyroidectomy for thyroid carcinoma. Endocrinol Metab Clin North Am. 2003;32:483– 502.
20. Page C, Strunski V. Parathyroid risk in total thyroidectomy for bi- lateral, benign, multinodular goiter: Report of 351 surgical cases. J Laryngol Otol. 2007;121:237–41.
21. Carter AB, Howanitz PJ. Intraoperative testing for parathyroid hormone: a comprehensive review of the use of the assay and the relevant literature. Arch Pathol Lab Med 2003;127:1424–42.
22. Moor JW, Roberts S, Atkin SL, England RJA. Intraoperative parathyroid hormone monitoring to determine long-term success of total parathyroidectomy for secondary hyperparathyroidism. Head Neck 2011;33:193–6.
23. Stewart AF. Hypercalcemia associated with cancer. N Engl J Med 2005;352:373–9.
24. Seymour JF, Gagel RF. Calcitriol: the major humoral mediator of hypercalemia in Hodgkin's disease and non-Hodgkin's lymphoma. J Am Soc Hematol 1993;82: 1383–94.
25. Souberbielle J-C, Roth H, Fouque DP. Parathyroid hormone measurement in CKD. Kidney Int 2010;77:93–100.
26. Moe SM. Management of renal osteodystrophy in peritoneal dialysis patients. Perit Dial Int. 2004 May-Jun;24(3):209-16.
27. Martin KJ, Olgaard K, Coburn JW, et al.Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy. Am J Kidney Dis. 2004 Mar;43(3):558-65
28. Salusky IB, Goodman WG. Adynamic renal osteodystrophy: is there a problem? J Am Soc Nephrol. 2001 Sep;12(9):1978-85.